Oncology CT

Study findings further highlight the central role of PET/CT in disease response after CAR-T cell therapy.

Cost, lower literacy levels and fear of lung cancer diagnosis were highlighted as concerns with lung cancer screening.

PSMA PET is highly robust in identifying prostate cancer lesions which are otherwise deemed unremarkable.

Patients with hepatocellular carcinoma may benefit from early PET/CT imaging after transarterial radioembolization to predict treatment response and survival, a new study found.

Clinicians taking care of patients with high-risk prostate cancer being assessed for prostatectomy can use a positive PET scan as a true positive, but a negative scan cannot be used to exclude disease or inform nodal dissection.

Diagnostic Imaging sat down with medical physicist and CT expert Cynthia H. McCollough, PhD, to learn more about the history of CT and its expanding potential in medical imaging.

The approval represents the first major technological advance in CT in nearly a decade.

Screening for COVID-19 exposure, particularly for patients with cancer on active treatment, has become a priority during the pandemic.

Clinicians, especially those working in a region of high COVID-19 prevalence, should be aware that FDG PET/CT can detect lung and lymph node findings suggestive of COVID-19.

Both board-certified radiologists and radiology residents more appropriately suggested chest CT follow-up when using artificial intelligence with chest X-ray.

Measurements can help predict which tumors will respond to targeted therapies.

Take a quick look at Diagnostic Imaging's Top 5 stories of the week.

American College of Chest Physicians has published new expert panel guidance around the use of low-dose CT.

Having the right technology in place can boost patient confidence in therapy.

The potential opportunities are numerous for virtual biopsies, radiomics, and radiogenomics.

Take a quick look at Diagnostic Imaging's Top 5 stories of the week.

Using PET/CT images to assess the level of a non-small cell lung cancer biomarker can help patients avoid invasive biopsy.

Recently approved PMSA-targeted radiotracer can pinpoint biochemical recurrent prostate cancer in men with unhelpful standard imaging.

Take a quick look at Diagnostic Imaging's Top 5 stories of the week.

Patients who have their disease detected with low-dose CT have a half-fold risk of brain metastasis than patients screened with other methods.

Take a quick look at Diagnostic Imaging's Top 5 stories of the week.

Using advanced PET imaging instead of just traditional imaging alone can improve outcomes for patients with prostate cancer.

Take a quick look at Diagnostic Imaging's Top 5 stories of the week.

Using a deep learning algorithm enables providers to screen high-risk patients for both lung cancer and cardiovascular disease.

Take a quick look at Diagnostic Imaging's Top 5 stories of the week.